ECC 2013: Late Breaking Clinical Trials: ASPECCT
by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.
by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.
The spouses of people suffering from chronic pain not only face an elevated risk of developing pain themselves. There is also a relationship between symptoms of helplessness, anxiety… read more.
In part, women and men differ from each other considerably not only in the way they perceive and cope with pain and in various comorbidities. Therapies can also… read more.
Asthma is still a serious public health issue affecting approximately 30 million people in Western Europe at a cost of around 17.7 billion Euro. There are efficacious treatments… read more.
Functional abdominal pain in childhood was associated with anxiety disorder and depression in teens and young adults, even if the stomach pain went away, a longitudinal study showed.
by Bruce Sylvester – Research presented on September 26, 2013 the European Association for the Study of Diabetes (EASD) annual meeting in Barcelona, Spain, indicates that type 2… read more.
by Bruce Sylvester – Alogliptin treatment of patients with type 2 diabetes and with high cardiovascular risk due to recent acute coronary syndromes has led to similar rates… read more.
by Bruce Sylvester – Researchers report that, after a decade when prescription opioid use has grown dramatically, identification and treatment of pain has not improved, and, notably, the… read more.
Among patients with non-ST-segment elevation acute coronary syndrome (ACS), pretreatment with prasugrel before angiography did not improve outcomes and worsened bleeding, a randomized trial showed.
Study presenter Deepak Bhatt (pictured) – The anti-hyperglycemic agent saxagliptin neither increased or decreased therate of ischemic events when added to standard of care in patients with type… read more.
A review of the presentation by Volker Heinemann (pictured). The decision on first line treatment in mCRC matters because the number of patients benefitting from therapy diminishes with… read more.
by Pam Harrison – MSI status has clear prognostic value in stage II CRC Julien Taieb, MD, PhD, University of Paris Descartes, Paris, France Microsatellite instability (MSI), a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.